ArticlePloS one2019

Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer.

Lucas Maahs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.